The efficacy of software to help patients understand drug costs for treatment for breast cancer

The efficacy of software to help patients understand drug costs for treatment for breast cancer - The efficacy of software to help patients understand drug costs for treatment for breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039904

Enrollment

116

Registered

2020-03-23

Start date

2019-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Using software of calculating drug costs Disuding software of calculating drug costs

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with metastatic or advanced breast cancer 2. Patients who have started or plan to change drug therapy for metastatic or advanced breast cancer 3. Patients who have two or more treatments presented by the attending physician 4. Patients who have been given sufficient explanations to participate in this study and have given their full understanding and informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with dementia 2. Patients who do not have to pay for the drug 3. Patients who are judged inappropriate by the Investigator

Design outcomes

Primary

Measure	Time frame
Comparing the two groups' questionnaire scores on 1. patients' perceived level of understanding of the drug cost 2. patients' perception that drug cost is important	—

Countries

Japan

Contacts

Public ContactSayaka Kuba

Nagasaki University Graduate School of Biomedical Science Surgery

skuba@nagasaki-u.ac.jp0958497316

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026